Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
9 Results for "
RAB7A
" in MedChemExpress (MCE) Product Catalog:
Products (9)
9 Results for "RAB7A" in MCE Product Catalog:
1
1 Cited Publications
Cat. No.: HY-P80295
Synonyms: CMT2B antibody;
PRO2706 antibody;
PSN antibody;
RAB7, member RAS oncogene family antibody;
RAB7A antibody;
RAB7A, member RAS oncogene family antibody;
RAB7A_HUMAN antibody;
Ras associated protein RAB7 antibody;
Ras related protein RAB7 antibody;
Ras related protein RAB7A antibody
Cat. No.: HY-RS11576
Target:
Research Areas:
RAB7A Human Pre-designed siRNA Set A contains three designed siRNAs for RAB7A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS23154
Target:
Research Areas:
Rab7a Rat Pre-designed siRNA Set A contains three designed siRNAs for Rab7a gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS29509
Target:
Research Areas:
Rab7a Mouse Pre-designed siRNA Set A contains three designed siRNAs for Rab7a gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.
Components
Rab7a siRNA-1: 5 nmol (HPLC)
Rab7a siRNA-2: 5 nmol (HPLC)
Rab7a siRNA-3: 5 nmol (HPLC)
siRNA Negative Control: 5 nmol (HPLC)
FAM-labeled siRNA Negative Control: 5 nmol (HPLC)
GAPDH siRNA Positive Control: 5 nmol (HPLC)
Components
Rab7a siRNA-1: 5 nmol (HPLC)
Rab7a siRNA-2: 5 nmol (HPLC)
Rab7a siRNA-3: 5 nmol (HPLC)
siRNA Negative Control: 5 nmol (HPLC)
FAM-labeled siRNA Negative Control: 5 nmol (HPLC)
GAPDH siRNA Positive Control: 5 nmol (HPLC)
Cat. No.: HY-P75998A
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: Ras-related protein RAB-7A; Ras-related protein BRL-RAS; RAB7A; RAB7
Cat. No.: HY-183772
Target:
Research Areas:
TBC1D2-IN-1 is a potent orally active and selective TBC1D2 inhibitor with a Kd of 1.1 μM. TBC1D2-IN-1 selectively inhibits TBC1D2-mediated GTP hydrolysis on RAB7A-GTP, promotes RAB7A accumulation on lysosomal membranes, and induces apoptosis and autophagy. TBC1D2-IN-1 exerts selective antiproliferative activity cancer cells. TBC1D2-IN-1 can be used for the research of cervical carcinoma .
Cat. No.: HY-187218
TBC1D2-IN-2 is an orally potent TBC1D2 inhibitor that binds to the TBC1D2 PH domain with a KD of 0.4 μM. TBC1D2-IN-2 induces autophagic cell death by reducing TBC1D2 protein levels, promoting RAB7A aggregation and enhancing autophagy. TBC1D2-IN-2 can be used in the research of hepatocellular carcinoma .
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
